Centogene reports third-quarter 2020 financial results and increases full year guidance

Cambridge, mass. and rostock, germany and berlin, dec. 16, 2020 (globe newswire) -- centogene n.v. (nasdaq: cntg) (“centogene” or the “company”), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today provided an update on its corporate progress and reported its financial results for the three and nine months ended september 30, 2020.
CNTG Ratings Summary
CNTG Quant Ranking